UPDATE 3-Lonza fills portfolio hole by buying Novartis drug bottling plant [Reuters]
LONZA GROUP AG UNSP/ADR (LZAGY)
NASDAQ:AMEX Investor Relations:
lonza.com/about-lonza/investor-relations.aspx
Company Research
Source: Reuters
Lonza fills portfolio hole by buying Novartis drug bottling plant - Reuters 3 Min Read ZURICH (Reuters) - Lonza Group is buying a drug bottling plant from Novartis in northern Switzerland as the Swiss drug ingredients maker fills a gap in its offering for drugmakers seeking to outsource production. Novartis is selling the so-called “fill and finish” facility because its production lines had been underutilized. Lonza has been building up its drug products services business for three years and has been weighing whether to buy a factory from a rival where it can put the finishing touches on injectible medicines, or build such a facility itself like it is doing now in Visp, Switzerland. [ reut.rs/32272tu ] In buying Novartis’s 10-year-old plant in Stein, Lonza will be able to speed up work for customers seeking to take their injectible medicines quickly into the clinic and onto the market, in particular for smaller lots of medicines aimed at niche populations, a Lonza spokeswoman said. “B
Show less
Read more
Impact Snapshot
Event Time:
LZAGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LZAGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LZAGY alerts
High impacting LONZA GROUP AG UNSP/ADR news events
Weekly update
A roundup of the hottest topics
LZAGY
News
- Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionPR Newswire
- Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionPR Newswire
- Lonza Group AG (OTCMKTS: LZAGY) was upgraded by analysts at Redburn Atlantic to a "strong-buy" rating.MarketBeat
- Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADCPR Newswire
- Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADCPR Newswire
LZAGY
Analyst Actions
- 10/17/24 - KEPLER CHEUVREUX